• Explore /
  • Poster
  • / Blood-based biomarkers in metastatic colorectal cancer patients treated with FOLFIRI plus regorafenib or placebo: Results from LCCC1029.

Blood-based biomarkers in metastatic colorectal cancer patients treated with FOLFIRI plus regorafenib or placebo: Results from LCCC1029.

Abstract Poster

Authors

Yingmiao Liu

Yingmiao Liu

Duke University Medical Center, Durham, NC

Yingmiao Liu , Kirsten Burdett , Mark D. Starr , J. Chris Brady , Ace Joseph Hatch , Anastasia Ivanova , Dominic T. Moore , Kelli Hammond , Michael Sangmin Lee , Bert O'Neil , Federico Innocenti , Kouros Owzar , Hanna Kelly Sanoff , Andrew B. Nixon

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Cancers of the Colon, Rectum, and Anus

Sub Track

Translational Research

Citation

J Clin Oncol 37, 2019 (suppl 4; abstr 587)

DOI

10.1200/JCO.2019.37.4_suppl.587

Abstract #

587

Poster Bd #

H10

Abstract Disclosures

Similar Posters

First Author: Satoshi Yuki

First Author: Andrew B. Nixon

First Author: Michael Sangmin Lee

First Author: Satoshi Yuki